Crossmark

Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.04.007

Published Print: 2023-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fernández-Prada, María

Pérez-Martín, Jaime Jesús

Cienfuegos-González, Paula
License Information

Text and Data Mining valid from 2023-05-01

stm-asf valid from 2023-05-01

stm-asf valid from 2023-05-01

stm-asf valid from 2023-05-01

stm-asf valid from 2023-05-01

stm-asf valid from 2023-05-01
More Information

This article is maintained by: Elsevier

Article Title: Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.04.007

Content Type: simple-article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.